| (210) | Number of the EPO application | 15872796 |
| (220) | Filing date of the EPO application | 2015.12.14 |
| (80) | EPO patent specification publication (B) | EPB nr. 35/2019, 2019.08.28 |
| (110) | EPO patent number | 3238717 |
| (21) | Number of the application | e 2017 0241 |
| (71) | Name(s) of applicant(s), code of the country | Hisamitsu Pharmaceutical Co., Inc., JP; |
| (72) | Name(s) of inventor(s), code of the country | TSURUSHIMA Keiichiro, JP;
KOSE Yasuhisa, JP;
YOSHINAGA Takaaki, JP; |
| (73) | Name(s) of owner(s), code of the country | HISAMITSU Pharmaceutical Co. Inc., JP; |
| (54) | Title of the invention | CATAPLASM |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 9/70 (2006.01.01); A61K 47/34 (2017.01.01); A61K 47/14 (2017.01.01); A61K 47/26 (2006.01.01); A61K 31/618 (2006.01.01) |
| (19) | Country | JP |
| (41) | Date of publication of the application | 2018.01.31 |
| (30) | Priority | 2014258879, 2014.12.22, JP; 2015178693, 2015.09.10, JP |
| (86) | International application | PCT/JP2015/084971, 2015.12.14 |
| (87) | International publication | WO 2016/104227, 2016.06.30 |